Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
J287969-5mg | 5mg | In stock | $78.90 | |
J287969-10mg | 10mg | In stock | $127.90 | |
J287969-50mg | 50mg | In stock | $395.90 | |
J287969-100mg | 100mg | In stock | $712.90 | |
J287969-250mg | 250mg | In stock | $1,603.90 | |
J287969-500mg | 500mg | In stock | $2,886.90 |
Potent and selective reversible MAGL inhibitor
Synonyms | [4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]-1H-1,2,4-triazol-1-ylmethanone | [4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-(1,2,4-triazol-1-yl)methanon |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Potent and selective reversible MAGL inhibitor (IC50= 46 nM). Exhibits 35-fold and 150-fold higher selectivity over human FAAH and ABHD6, respectively (IC50values are 1.79 and 7.24μM, respectively). Displays affinity for H1receptors (pA2= 6.81). Exhibits |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | [4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-(1,2,4-triazol-1-yl)methanone |
---|---|
INCHI | InChI=1S/C22H20ClN5O/c23-18-5-6-19-17(12-18)4-3-16-2-1-9-25-21(16)20(19)15-7-10-27(11-8-15)22(29)28-14-24-13-26-28/h1-2,5-6,9,12-14H,3-4,7-8,10-11H2 |
InChi Key | GAVZCGTYRWKKDV-UHFFFAOYSA-N |
Canonical SMILES | C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)N4C=NC=N4)C5=C1C=CC=N5 |
Isomeric SMILES | C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)N4C=NC=N4)C5=C1C=CC=N5 |
PubChem CID | 102596130 |
Molecular Weight | 405.88 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2312224 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312225 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312228 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312230 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312233 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312234 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312235 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312236 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312237 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312241 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312242 | Certificate of Analysis | May 10, 2023 | J287969 |
F2312244 | Certificate of Analysis | May 10, 2023 | J287969 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 40.59, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 8.12, Max Conc. mM: 20 |
---|